You are using an outdated browser. Please upgrade your browser to improve your experience.
Moffitt Malignant Hematology and Cellular
Therapy Program at Memorial Health System
703 N. Flamingo Road
Pembroke Pines, FL 33028
Direct phone: 954-265-4325
Total transplants by cell source
- Marrow: 2
- PBSC: 74
- Cord Blood: 0
- Autologous (PBSC or Marrow): 78
About the center
The Moffitt Malignant Hematology and Cellular Therapy Program at Memorial Healthcare System is at a comprehensive cancer center for patients in South Florida that provides high-quality, individualized treatments for patients requiring autologous and allogeneic stem cell transplantation, or immune effector cell therapy. The program is accredited by the Foundation for the Accreditation of Cellular Therapies (FACT) and areas of interest are MDS/AML, BMT for the elderly (above 70), Haploidentical Transplant and treatment of GVHD. This center has been performing allogeneic transplants since 2013 and has been an NMDP/Be The Match transplant center since July 2018.
This center has been performing allogeneic transplants since 2013 and has been an NMDP/Be The Match transplant center since July 2018.
Adult - Yehuda Deutsch, Hugo Fernandez, Jose Sandoval-Sus, Fernando Vargas
Cord blood transplants performed on
Other programs and services
Social Work services. Discounted local hotels.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2018, 2019, 2020, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 90 patients.
The actual 1-year survival of these patients is 74.4%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 63.2% and 81.0%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2020 to December 31st, 2021 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2020 to December 31st, 2021 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
- U.S. Transplant Data by Center report at bloodcell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinator:
If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)
No survivorship program information is available. Contact the center for information about post-transplant care.